Hebei Mujin Biotechnology Co.,Ltd
Assessed Supplier Enterprise Certification
- Assessed
Supplier - 6th
years
Assessed Supplier Enterprise Certification
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Trading Company
Tel: 13231137666
Tel: 15028179902
Tel: 13383610321
Tel: +86 13288715578
Tel: +86 13288715308
Tel: +86 15028179772
Tel: +86 13315458396
Tel: 15103291926
Tel: 13315457394
Mobile: 13231137666
Tel: 13231137666
Fax:
Province/state: Hebei
City: shijiazhuang
Street: room 1401,A building,Enjoy city,shijiazhuang city,hebei province,China
MaxCard:
Ms.betty Ms.mayCAS NO.100986-85-4
medical (1-25)Metric Tonmedical (25-1000)Metric Tonpharmaceutical(1-25)Metric Ton
Our company have high quality product , and also the product we have good manufacture .
First of all, this product is of fine quality. Every finish should be checked by quality inspection system.And every one should be also tried out for one month.Besides，this type has a good viscosity. the prouct can make Gel hand sanitizer thickener cosmetics industry.
We can ensure the product quality , If the product is not satisfactory, you can return it at any time.
our product have resonable price and good service high quality and inexpensive, you deserve.every webiste we have the sales point, your purchase is convenient.
Any time on line , from 0.00-24:00 . if you have any questions , pls contact with me ,As long as you have the need, we will serve you wholeheartedly
| Product Name: | Levofloxacin hydrochloride |
| Synonyms: | (s)-ofloxacin;7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-;Cravit;HR 355;Levaquin;RWJ 25213-097;Tavanic;(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid |
| CAS: | 100986-85-4 |
| MF: | C18H20FN3O4 |
| MW: | 361.37 |
| EINECS: | 600-146-0 |
| Product Categories: | Peptide Synthesis/Antibiotics;Pharmaceutical intermediate;Active Pharmaceutical Ingredients;Antibiotics for Research and Experimental Use;Biochemistry;Quinolones (Antibiotics for Research and Experimental Use);Pharmaceutical material and intermeidates;Anti-Infective;Antimicrobial;API;Pharmaceutical intermediates;Inhibitors |
| Mol File: | 100986-85-4.mol |
| Levofloxacin hydrochloride Chemical Properties |
| Melting point | 218°C |
| Boiling point | 572℃ |
| density | 1.48±0.1 g/cm3(Predicted) |
| Fp | >110°(230°F) |
| storage temp. | Keep in dark place,Sealed in dry,2-8°C |
| solubility | chloroform: soluble10mg/mL |
| pka | 5.19±0.40(Predicted) |
| form | powder |
| color | white to faint yellow |
| optical activity | [α]20/D -104±4° in chloroform |
| Water Solubility | Slightly soluble in water or methanol. Soluble in glacial acetic acid or dichloromethane |
| Sensitive | Light Sensitive |
| Merck | 14,6771 |
| BRN | 7327015 |
| InChIKey | GSDSWSVVBLHKDQ-JTQLQIEISA-N |
| CAS DataBase Reference | 100986-85-4(CAS DataBase Reference) |
| EPA Substance Registry System | 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)- (100986-85-4) |
| Safety Information |
| Hazard Codes | Xn |
| Risk Statements | 22-42/43-68-20/21/22-64-63 |
| Safety Statements | 26-36/37/39-36 |
| RIDADR | UN 1648 3 / PGII |
| WGK Germany | 3 |
| RTECS | UU8815550 |
| HS Code | 29349990 |
| Hazardous Substances Data | 100986-85-4(Hazardous Substances Data) |
| Toxicity | LD50 oral in rat: 1478mg/kg |